The largest database of trusted experimental protocols

5 protocols using ppackh1 rev

1

Lentiviral Transduction and Cell Establishment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-proliferative lentivirus was packaged using the lentivirus packaging system purchased from the System Biosciences. Briefly, the pCDH 5aCON-Nluc G2P or pCDH 9xGAL4UAS-Nluc R2P plasmids were mixed with a pPACKH1 plasmid mix consisting of pPACKH1-GAG, pPACKh1-REV, and pVSV-G (System Biosciences), and then transfected into COS1 cells using X-tremeGENE 9 DNA Transfection Reagent (Roche, Basel, Switzerland). After 36 h, the culture medium was filtered through a 0.45 µm syringe filter and directly added to the PC3 cells not expressing PAX6. The infected cells were then cultured with 10 µg/mL puromycin (ant-pr; InvivoGen, San Diego, CA, USA) for more than 2 weeks to establish the PC3-5aNluc and PC3-9Gal4Nluc cells.
+ Open protocol
+ Expand
2

Lentiviral Transduction of Scp-1 and PASC-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following plasmids were used for stable lentiviral transduction of Scp-1 and PASC-1 cells: pPACKH1-GAG, pPACKH1-REV, pVSV-G (Systems Biosciences), pLV-[mir-control], pLV-[mir-181a] (Biosettia), pEZX-AM04-cmiR, pEZX-AM04-anti-miR-181a (Genecopeia), pshPER3 #1 TRCN0000018503, pshPER3 #2 TRCN0000018506, pLKO.1-puro Non-Target shRNA (Sigma), psi-LVRU6GP-shPPARG HSH064513, psi-LVRU6GP-shscram CSHCTR001-LVRU6GH (Genecopeia). For 3′UTR luciferase assays pEZX-MT06-PER3 HmiT021640-MT06 (Genecopeia) was used.
+ Open protocol
+ Expand
3

Cloning of MDK, WFDC2, and CXCL14 Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length gene sequences encoding MDK, WFDC2, and CXCL14 were obtained and cloned together with 6 × His tag into the lentiviral vector pCDH-CMV-MCS-EF1-Puro (CD510B-1, System Biosciences). Three packaging plasmids pPACKH1-GAG, pPACKH1-REV, and pVSV-G were obtained from the System Biosciences.
+ Open protocol
+ Expand
4

Lentiviral Transduction of FTSECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following plasmids were used for stable lentiviral transduction of FTSECs: pPACKH1-GAG, pPACKH1-REV, pVSV-G (Systems Biosciences), pLV-[mir-control], pLV-[mir-181a] (Biosettia), pEZX-AM04-cmiR, pEZX-AM04-anti-miR-181a (Genecopoeia), pshRB1 TRCN0000295842, pLKO.1-puro Non-Target shRNA (Sigma). For 3′UTR luciferase assays pEZX-MT06-RB1 HmiT021640-MT06 and pEZX-MT06-TMEM173 HmiT100627-MT06 (Genecopoeia) was used.
+ Open protocol
+ Expand
5

Lentiviral shRNA Knockdown in Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The shRNA expression cassettes were generated from DNA oligonucleotides (Sigma-Aldrich, see sequences in Table S3). shRNAs, under an H1 polymerase III promoter, comprised a 22-bp stem and 10-nt miR-23 loop. We used shScr (scrambled) or shLuc, which targets the luciferase gene, as negative controls of silencing. Pairs of oligonucleotides were annealed and ligated into the pGreenPuro (System Biosciences, Palo Alto, CA, USA) expression plasmid and verified through sequencing. For lentivirus production, the plasmids were cotransfected with the packaging plasmids pPACKH1-GAG, pPACKH1-REV, and pVSVG (System Biosciences) in HEK 293TN cells. The medium was collected at days 2 and 3, and the viral supernatants were passed through 0.45-μm filters and concentrated using PEGit Virus Precipitation Solution (System Biosciences). The lentiviral vectors were resuspended in Opti-MEM (GIBCO), and the virus titers (TU/mL) were determined through flow cytometry (Accuri C6, BD Biosciences) based on copGFP expression. The transduction of fibroblasts was performed at a MOI of 1 and/or 10 in the presence of polybrene (4 μg/mL). Total RNA and protein were harvested at 7 days posttransduction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!